Jeffrey Stein - Aug 18, 2021 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
President & CEO, Director
Signature
/s/ Jeffrey Stein
Stock symbol
CDTX
Transactions as of
Aug 18, 2021
Transactions value $
$86,755
Form type
4
Date filed
8/19/2021, 04:24 PM
Previous filing
Jun 16, 2021
Next filing
Nov 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDTX Common Stock Purchase $68.9K +40K +10.93% $1.72 406K Aug 18, 2021 Direct F1, F2
transaction CDTX Common Stock Purchase $17.9K +10K +2.46% $1.79 416K Aug 19, 2021 Direct F3
holding CDTX Common Stock 232K Aug 18, 2021 by trust
holding CDTX Common Stock 42K Aug 18, 2021 by son
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.6990 to $1.7300, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
F2 Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 20, 2021.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.7850 to $1.7899, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.